Corporate News     10-Nov-23
Themis Medicare launches novel Opioid Injectable Analgesic REMIFENTANIL
Themis Medicare announced the launch of a novel Opioid Injectable Analgesic REMIFENTANIL under its brand name REMITHEM® in the Indian market for use during induction of anesthesia, during immediate post operative period and in monitored anesthesia care.

Remifentanil® was first approved in USA in 1996 and has wide clinical usage & acceptance around the world in major markets including USA, Europe, Japan and other countries and is also well published.

Previous News
  Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter
 ( Results - Announcements 27-Jul-24   07:34 )
  Themis Medicare Ltd Surges 3.83%
 ( Hot Pursuit - 10-Nov-21   09:30 )
  Themis Medicare to hold board meeting
 ( Corporate News - 17-Jul-24   09:49 )
  Themis Medicare standalone net profit rises 373.94% in the June 2021 quarter
 ( Results - Announcements 13-Aug-21   14:35 )
  Themis Medicare to hold board meeting
 ( Corporate News - 18-Jul-15   17:25 )
  Board of Themis Medicare recommends final dividend
 ( Corporate News - 28-May-21   14:44 )
  Themis Medicare net profit rises 104.35% in the June 2014 quarter
 ( Results - Announcements 06-Aug-14   08:53 )
  Themis Medicare to hold board meeting
 ( Corporate News - 22-Oct-14   12:15 )
  Themis Medicare to issue 3 lakh warrants on preferential basis
 ( Corporate News - 28-Oct-06   15:05 )
  Themis Medicare climbs after Viralex gets add on approval from DCGI
 ( Hot Pursuit - 18-May-22   13:20 )
  Themis Medicare allots 2,500 equity shares under ESOS
 ( Corporate News - 27-Jan-23   17:16 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top